Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Barnes

Showing results (461-470 of 474) with videos related to

Pageof 48
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2015
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosisSudarshini Ramanathan, Kristina Prelog, Elizabeth H Barnes, et al.
Scientific Reports|October 25, 2017
IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesisNehal N Mehta, Heather L Teague, William R Swindell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trialA P Barbour, E T Walpole, G T Mai, et al.
JCI Insight|September 7, 2018
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary preventionPiyushkumar A Mundra, Christopher K Barlow, Paul J Nestel, et al.
Circulation|October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusZahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
Frontiers in Bioengineering and Biotechnology|November 17, 2022
New self-sexing <i>Aedes aegypti</i> strain eliminates barriers to scalable and sustainable vector control for governments and communities in dengue-prone environmentsSiân A M Spinner, Zoe H Barnes, Alin Mirel Puinean, et al.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Cancer Research|April 15, 2015
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical ModelsCatherine A Eberlein, Daniel Stetson, Aleksandra A Markovets, et al.
BMJ Open|May 15, 2023
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot studyBenjamin Y Kong, Hao-Wen Sim, Anna K Nowak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitorsJ M Riedl, F Fece de la Cruz, J J Lin, et al.
Pageof 48

Showing results (461-470 of 474) with videos related to

Sort By:
Pageof 48
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2015
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosisSudarshini Ramanathan, Kristina Prelog, Elizabeth H Barnes, et al.
Scientific Reports|October 25, 2017
IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesisNehal N Mehta, Heather L Teague, William R Swindell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trialA P Barbour, E T Walpole, G T Mai, et al.
JCI Insight|September 7, 2018
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary preventionPiyushkumar A Mundra, Christopher K Barlow, Paul J Nestel, et al.
Circulation|October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusZahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
Frontiers in Bioengineering and Biotechnology|November 17, 2022
New self-sexing <i>Aedes aegypti</i> strain eliminates barriers to scalable and sustainable vector control for governments and communities in dengue-prone environmentsSiân A M Spinner, Zoe H Barnes, Alin Mirel Puinean, et al.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
Cancer Research|April 15, 2015
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical ModelsCatherine A Eberlein, Daniel Stetson, Aleksandra A Markovets, et al.
BMJ Open|May 15, 2023
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot studyBenjamin Y Kong, Hao-Wen Sim, Anna K Nowak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitorsJ M Riedl, F Fece de la Cruz, J J Lin, et al.
Pageof 48